nifedipine has been researched along with Cardiac Hypertrophy in 91 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sixteen patients with severe hypertension were treated for 1 year with extended release nifedipine, during which time serial changes in left ventricular mass index and associated alterations in left ventricular systolic function, left ventricular filling, plasma renin activity, atrial natriuretic peptide and catecholamines were evaluated." | 9.07 | Normalization of left ventricular mass and associated changes in neurohormones and atrial natriuretic peptide after 1 year of sustained nifedipine therapy for severe hypertension. ( Ardeljan, M; Eison, HB; Garbowit, DL; Goldman, ME; Krakoff, LR; Phillips, RA; Shimabukuro, S, 1991) |
| "The effects of two antihypertensive agents, nifedipine (N) and captopril (C), on left ventricular (LV) mass and volume were studied in 16 patients with essential hypertension (8 treated with N and 8 with C for 6 months) by means of a complete M-mode echocardiogram monitored by two-dimensional echocardiography." | 9.06 | Regression of cardiac hypertrophy after antihypertensive therapy with nifedipine and captopril. ( Accardi, R; Arcaro, G; Covi, G; Lechi, A; Sheiban, I; Zenorini, C, 1987) |
| "Nifedipine was used successfully in nine patients with refractory hypertension and left ventricular hypertrophy who had symptoms of congestive heart failure despite preserved left ventricular systolic function." | 7.67 | Nifedipine in severely hypertensive patients with congestive heart failure and preserved ventricular systolic function. ( Dzau, VJ; Given, BD; Lee, TH; Stone, PH, 1985) |
| "The effect of long-term treatment with the calcium antagonist nisoldipine on development of hypertension, cardiac hypertrophy, and plasma levels of atrial natriuretic peptides (ANP) was determined in spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY) of the same age." | 7.67 | Role of nisoldipine on blood pressure, cardiac hypertrophy, and atrial natriuretic peptides in spontaneously hypertensive rats. ( Hirth, C; Kazda, S; Morich, F; Stasch, JP, 1987) |
| "We designed experiments to determine whether intermittent hypoxia would produce significant pathologic and physiologic changes in rats and whether pretreatment with a calcium channel blocker, nitrendipine, would reduce the pulmonary vascular remodeling and right ventricular hypertrophy caused by intermittent hypoxia." | 7.67 | Nitrendipine attenuates the pulmonary vascular remodeling and right ventricular hypertrophy caused by intermittent hypoxia in rats. ( Buescher, P; de la Monte, SM; Farrukh, I; Gottlieb, J; Gurtner, G; Hutchins, GM; Kennedy, TP; Lodato, R; Michael, JR; Rock, PC, 1986) |
| " It was found that in a part of patients the long-term administration of antihypertensive drugs led to an increased accumulation of kynurenine as a manifestation of pyridoxal-5-phosphate deficiency." | 5.28 | Increased blood kynurenine level as a factor inhibiting the therapeutic effect of antihypertensive agents in combined long-term treatment of essential hypertension. ( Liepinja, DJ; Rudzite, VK; Silava, AK; Vitols, AV, 1990) |
| "Nifedipine did not produce any depression of contractile and pump functions of the heart." | 5.28 | [Nifedipine in the treatment of hypertension. An echocardiographic assessment of the hemodynamic effects]. ( Bobrov, VA; Konoshevich, SN, 1989) |
| "Amlodipine is a long-acting dihydropyridine-based calcium antagonist developed for use on a once-a-day basis." | 5.27 | The effect of amlodipine on hypertension-induced cardiac hypertrophy and reperfusion-induced calcium overload. ( Nayler, WG, 1988) |
| "Sixteen patients with severe hypertension were treated for 1 year with extended release nifedipine, during which time serial changes in left ventricular mass index and associated alterations in left ventricular systolic function, left ventricular filling, plasma renin activity, atrial natriuretic peptide and catecholamines were evaluated." | 5.07 | Normalization of left ventricular mass and associated changes in neurohormones and atrial natriuretic peptide after 1 year of sustained nifedipine therapy for severe hypertension. ( Ardeljan, M; Eison, HB; Garbowit, DL; Goldman, ME; Krakoff, LR; Phillips, RA; Shimabukuro, S, 1991) |
| "The effects of two antihypertensive agents, nifedipine (N) and captopril (C), on left ventricular (LV) mass and volume were studied in 16 patients with essential hypertension (8 treated with N and 8 with C for 6 months) by means of a complete M-mode echocardiogram monitored by two-dimensional echocardiography." | 5.06 | Regression of cardiac hypertrophy after antihypertensive therapy with nifedipine and captopril. ( Accardi, R; Arcaro, G; Covi, G; Lechi, A; Sheiban, I; Zenorini, C, 1987) |
| "The calcium channel blocker (CCB), nifedipine, is a more effective treatment for early- than late-stage cardiac hypertrophy." | 3.83 | Early administration of nifedipine protects against angiotensin II-induced cardiomyocyte hypertrophy through regulating CaMKII-SERCA2a pathway and apoptosis in rat cardiomyocytes. ( Du, YM; Luo, J; Zhang, WD, 2016) |
| " The pharmacokinetics of verapamil and of one of its metabolites, norverapamil, is changed after multiple oral dosing as has been described in patients with supraventricular tachyarrhythmias, angina pectoris or in patients with essential hypertension." | 3.76 | Pharmacokinetics of calcium channel blocking agents. ( Anderson, P, 1986) |
| "The three treatments regressed cardiac hypertrophy and normalized sodium/hydrogen ion exchange exchange activity in SHR, and losartan was the most effective treatment for reversing cardiac hypertrophy, despite producing effects on blood pressure and sodium/hydrogen exchange activity similar to that of other antihypertensive drugs." | 3.71 | Effects of antihypertensive therapy on cardiac sodium/hydrogen ion exchanger activity and hypertrophy in spontaneously hypertensive rats. ( Alvarez, BV; Cingolani, HE; De Hurtado, MC; Ennis, IL, 2002) |
| "Angiotensin II plays an important role in the development of cardiac hypertrophy." | 3.70 | Effects of taurine on signal transduction steps induced during hypertrophy of rat heart myocytes. ( Rao, MR; Tao, L, 1998) |
| " Endothelin-1 (ET-1), one of the endogenous pathological humoral factors of cardiovascular diseases such as hypertension and heart failure, has a strong vasoconstrictive action and could induce hypertension and cardiac hypertrophy." | 3.70 | Possible involvement of endothelin-1 in cardioprotective effects of benidipine. ( Akashi, T; Harada, M; Hosoya, T; Ikeda, K; Nakagawa, O; Nakao, K; Tojo, K; Tokudome, G, 2000) |
| " Mibefradil treatment resulted in lower blood pressure, reduced cardiac hypertrophy, near-normal structure of conduit and small arteries and lower endothelin-1 mRNA abundance." | 3.69 | Effect of antihypertensive treatment and N omega-nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats. ( Li, JS; Schiffrin, EL; Sventek, P, 1996) |
| "The aim of the present study was to define the protective effects of verapamil and nifedipine on mechanical performance and energy and substrate metabolism of the postischemically reperfused myocardium in a chronic pressure overload cardiac hypertrophy model." | 3.68 | Protective effects of calcium antagonists on energy and substrate metabolism during ischemia and reperfusion in hypertensive myocardial hypertrophy. ( Buser, PT; Higgins, CB; Wagner, S; Wikman-Coffelt, J; Wu, S, 1991) |
| "Fourteen patients with previously untreated essential hypertension and left ventricular hypertrophy were treated with a fixed-dose combination of acebutolol 200 mg and nifedipine 20 mg once daily for a followup of 25." | 3.67 | Regression of left ventricular hypertrophy by acebutolol and nifedipine. ( Behr, U; Franz, IW; Ketelhut, R; Tönnesmann, U, 1989) |
| " On this basis, functional and therapeutical regimen of regression of cardiac hypertrophy (prazosin, clonidine, nifedipine) are analyzed in concentric as well as in excentric hypertrophy in patients with arterial hypertension." | 3.67 | [Progression and regression of heart hypertrophy in arterial hypertension: pathophysiology and clinical aspects]. ( Strauer, BE, 1985) |
| "We designed experiments to determine whether intermittent hypoxia would produce significant pathologic and physiologic changes in rats and whether pretreatment with a calcium channel blocker, nitrendipine, would reduce the pulmonary vascular remodeling and right ventricular hypertrophy caused by intermittent hypoxia." | 3.67 | Nitrendipine attenuates the pulmonary vascular remodeling and right ventricular hypertrophy caused by intermittent hypoxia in rats. ( Buescher, P; de la Monte, SM; Farrukh, I; Gottlieb, J; Gurtner, G; Hutchins, GM; Kennedy, TP; Lodato, R; Michael, JR; Rock, PC, 1986) |
| "The effect of long-term treatment with the calcium antagonist nisoldipine on development of hypertension, cardiac hypertrophy, and plasma levels of atrial natriuretic peptides (ANP) was determined in spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY) of the same age." | 3.67 | Role of nisoldipine on blood pressure, cardiac hypertrophy, and atrial natriuretic peptides in spontaneously hypertensive rats. ( Hirth, C; Kazda, S; Morich, F; Stasch, JP, 1987) |
| "Nifedipine was used successfully in nine patients with refractory hypertension and left ventricular hypertrophy who had symptoms of congestive heart failure despite preserved left ventricular systolic function." | 3.67 | Nifedipine in severely hypertensive patients with congestive heart failure and preserved ventricular systolic function. ( Dzau, VJ; Given, BD; Lee, TH; Stone, PH, 1985) |
| " Patients received a daily oral dosage of either 4 to 8 mg of perindopril or 40 to 80 mg of nifedipine in slow-release form." | 2.67 | Relation of regression of left ventricular hypertrophy to changes in ambulatory blood pressure after long-term therapy with perindopril versus nifedipine. ( Gotzen, R; Lenz, T; Liederwald, K; Meyer-Sabellek, W; Schulte, KL; van Gemmeren, D, 1992) |
| " Twenty-one patients with concentric LVH (thickness of interventricular septum, IVS, and left posterior wall, LPW, above 11 mm) were given a 2D and M-mode echocardiogram before (pre) and 12 and 24 weeks, respectively, after therapy was initiated (mean oral cl dosage 150 micrograms; nf, 30 mg/day)." | 2.66 | Effects of clonidine and nifedipine on left ventricular hypertrophy and muscle mass in hypertensive patients. ( Brückner, S; Kleine, P; Meissner, E; von Bruchhausen, V, 1987) |
| "Verapamil was discontinued in 2 patients who developed severe dyspnea at rest after 3-4 days of continued oral treatment." | 2.65 | Clinical use of calcium channel blockers as ventricular unloading agents. ( Agostoni, PG; Cipolla, C; Fabbiocchi, F; Guazzi, MD; Pepi, M; Sganzerla, P, 1983) |
| " This is a significant limitation because sustained changes in blood pressure are often accompanied by changes in heart rate and together can lead to cardiac hypertrophy and myocardial degeneration in animals, and major adverse cardiovascular events (MACE) in humans." | 1.43 | Natriuretic Peptides as Cardiovascular Safety Biomarkers in Rats: Comparison With Blood Pressure, Heart Rate, and Heart Weight. ( Engle, SK; Watson, DE, 2016) |
| "She had clinical features of systemic sclerosis (SSc) which was subsequently confirmed on further workup." | 1.39 | Recurrent cardiac tamponade in a young woman. ( Itolikar, M; Itolikar, SM; Phatak, S; Salagre, S, 2013) |
| "These diseases induce cardiac hypertrophy and increases in [Ca(2+)] are known to be an essential proximal signal for activation of hypertrophic genes." | 1.38 | Ca(2+) influx through L-type Ca(2+) channels and transient receptor potential channels activates pathological hypertrophy signaling. ( Barr, LA; Berretta, RM; Gao, H; Houser, SR; Kubo, H; Makarewich, CA; Molkentin, JD; Wang, F; Wang, W; Zhang, H, 2012) |
| "Regression of cardiac hypertrophy was accompanied by a 50% to 300% increase in DNA fragmentation and a >20% reduction in DNA synthesis, resulting in a >20% reduction in cardiac DNA content after 4 weeks." | 1.30 | Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats. Temporal regulation and spatial heterogeneity. ( Dam, TV; deBlois, D; Hamet, P; Moreau, P; Tea, BS, 1999) |
| " Co-administration with propranolol markedly decreased the heart rate, but little affected the heart weight, suggesting changes in the heart rate during the long-term administration of KW-3049 did not largely affect cardiac hypertrophy." | 1.29 | Effect of the new calcium antagonist (+/-)-(R*)-3-[(R*)-1-benzyl-3- piperidyl] methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5- pyridinedicarboxylate hydrochloride (KW-3049) on cardiac hypertrophy in spontaneously hypertensive rats. ( Deguchi, T; Hara, T; Hattori, O; Kato, Y; Saijyo, T; Suzuki, K; Tanaka, H, 1993) |
| "Concomitantly, cardiac hypertrophy was attenuated in the treated group compared with the placebo group (heart-to-body weight ratios of 4." | 1.28 | Vascular injury: mechanisms and manifestations. ( Nayler, WG, 1991) |
| "Nifedipine did not produce any depression of contractile and pump functions of the heart." | 1.28 | [Nifedipine in the treatment of hypertension. An echocardiographic assessment of the hemodynamic effects]. ( Bobrov, VA; Konoshevich, SN, 1989) |
| " It was found that in a part of patients the long-term administration of antihypertensive drugs led to an increased accumulation of kynurenine as a manifestation of pyridoxal-5-phosphate deficiency." | 1.28 | Increased blood kynurenine level as a factor inhibiting the therapeutic effect of antihypertensive agents in combined long-term treatment of essential hypertension. ( Liepinja, DJ; Rudzite, VK; Silava, AK; Vitols, AV, 1990) |
| "Amlodipine is a long-acting dihydropyridine calcium antagonist with vascular selectivity." | 1.28 | Vascular and myocardial effects of amlodipine: an overview. ( Gu, XH; Nayler, WG, 1991) |
| "Amlodipine is a long-acting dihydropyridine-based calcium antagonist developed for use on a once-a-day basis." | 1.27 | The effect of amlodipine on hypertension-induced cardiac hypertrophy and reperfusion-induced calcium overload. ( Nayler, WG, 1988) |
| "Renal function and salt and water turnover were studied in SHR during acute and chronic administration of felodipine, which is an efficient antihypertensive vasodilating Ca2+ antagonist." | 1.27 | Renal and cardiovascular effects of acute and chronic administration of felodipine to SHR. ( Di Bona, GF; Ljung, B; Nordlander, M; Thorén, P; Yao, T, 1985) |
| "Nifedipine therapy was associated with an improved LV filling in nearly all cases of HCM and HHD, and in some cases of IHD." | 1.27 | [Stress pulsed Doppler echocardiography in the evaluation of diastolic left ventricular function]. ( Asai, M; Fukuda, N; Ishimoto, T; Mori, H; Niki, T; Ohkushi, H; Oki, T; Taoka, M; Tominaga, T, 1985) |
| "In hypertensive cardiac hypertrophy, the elevated coronary perfusion pressure compensates importantly for the raised coronary resistance." | 1.27 | Electrocardiographic alterations suggestive of myocardial injury elicited by rapid pressure lowering in hypertension. ( Alimento, M; Guazzi, MD; Maltagliati, A; Pepi, M; Tosi, E, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 47 (51.65) | 18.7374 |
| 1990's | 32 (35.16) | 18.2507 |
| 2000's | 4 (4.40) | 29.6817 |
| 2010's | 8 (8.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itolikar, SM | 1 |
| Salagre, S | 1 |
| Phatak, S | 1 |
| Itolikar, M | 1 |
| Engle, SK | 1 |
| Watson, DE | 1 |
| Luo, J | 1 |
| Zhang, WD | 1 |
| Du, YM | 1 |
| Luo, Q | 1 |
| Xuan, WL | 1 |
| Xi, F | 1 |
| Liao, YL | 1 |
| Kitakaze, M | 1 |
| Veeramani, C | 1 |
| Aristatle, B | 1 |
| Pushpavalli, G | 1 |
| Pugalendi, KV | 1 |
| Ago, T | 1 |
| Yang, Y | 1 |
| Zhai, P | 1 |
| Sadoshima, J | 1 |
| Gao, H | 1 |
| Wang, F | 1 |
| Wang, W | 1 |
| Makarewich, CA | 1 |
| Zhang, H | 1 |
| Kubo, H | 1 |
| Berretta, RM | 1 |
| Barr, LA | 1 |
| Molkentin, JD | 1 |
| Houser, SR | 1 |
| Zhang, ZJ | 1 |
| Fan, YF | 1 |
| Zhang, ZY | 1 |
| Xie, PY | 1 |
| Fang, HC | 1 |
| Su, YS | 1 |
| Massie, BM | 1 |
| Hirsch, AT | 1 |
| Inouye, IK | 1 |
| Tubau, JF | 1 |
| Opie, LH | 2 |
| Senn, M | 1 |
| Hess, OM | 1 |
| Krayenbühl, HP | 1 |
| Wise, JR | 1 |
| Guazzi, MD | 5 |
| Cipolla, C | 1 |
| Sganzerla, P | 1 |
| Agostoni, PG | 2 |
| Fabbiocchi, F | 1 |
| Pepi, M | 4 |
| Loaldi, A | 1 |
| Fiorentini, C | 1 |
| Grazi, S | 1 |
| Della Bella, P | 1 |
| Dukes, ID | 1 |
| Vaughan Williams, EM | 1 |
| Oemar, H | 1 |
| Gutiérrez Palau, L | 1 |
| Bolaños Miñambres, IF | 1 |
| Lundin, SA | 1 |
| Hallbäck-Nordlander, MI | 1 |
| Narita, M | 1 |
| Kurihara, T | 1 |
| Murano, K | 1 |
| Usami, M | 1 |
| Honda, M | 1 |
| Kanao, K | 1 |
| Strauer, BE | 7 |
| Atef Mahmoud, M | 1 |
| Bayer, F | 1 |
| Bohn, I | 1 |
| Motz, U | 1 |
| Ewy, GA | 1 |
| Békés, M | 1 |
| Cserhalmi, L | 1 |
| Glavanov, M | 1 |
| Csukás, A | 1 |
| Szilágyi, M | 1 |
| Huszár, G | 1 |
| Giudicelli, JF | 1 |
| Freslon, JL | 1 |
| Richer, C | 1 |
| Hope, RR | 1 |
| Lazzara, R | 1 |
| Kato, Y | 1 |
| Tanaka, H | 1 |
| Saijyo, T | 1 |
| Hattori, O | 1 |
| Suzuki, K | 1 |
| Hara, T | 1 |
| Deguchi, T | 1 |
| Matsubara, H | 1 |
| Suzuki, J | 1 |
| Inada, M | 1 |
| Johnson, PL | 1 |
| Bhattacharya, SK | 1 |
| Li, JS | 1 |
| Sventek, P | 1 |
| Schiffrin, EL | 1 |
| Gómez, AM | 1 |
| Valdivia, HH | 1 |
| Cheng, H | 1 |
| Lederer, MR | 1 |
| Santana, LF | 1 |
| Cannell, MB | 1 |
| McCune, SA | 1 |
| Altschuld, RA | 1 |
| Lederer, WJ | 1 |
| Yamazaki, T | 2 |
| Komuro, I | 2 |
| Zou, Y | 2 |
| Kudoh, S | 1 |
| Shiojima, I | 1 |
| Mizuno, T | 1 |
| Hiroi, Y | 1 |
| Nagai, R | 2 |
| Yazaki, Y | 1 |
| Rao, MR | 1 |
| Tao, L | 1 |
| Murphy, RJ | 1 |
| Béliveau, L | 1 |
| Gardiner, PF | 1 |
| Calderone, A | 1 |
| Tea, BS | 1 |
| Dam, TV | 1 |
| Moreau, P | 1 |
| Hamet, P | 1 |
| deBlois, D | 1 |
| Kalliovalkama, J | 1 |
| Kähönen, M | 1 |
| Tolvanen, JP | 1 |
| Wu, X | 1 |
| Voipio, J | 1 |
| Pekki, A | 1 |
| Doris, PA | 1 |
| Ylitalo, P | 1 |
| Pörsti, I | 1 |
| Ikeda, K | 1 |
| Tojo, K | 1 |
| Tokudome, G | 1 |
| Akashi, T | 1 |
| Hosoya, T | 1 |
| Harada, M | 1 |
| Nakagawa, O | 1 |
| Nakao, K | 1 |
| Nakagawa, K | 1 |
| Yamada, H | 1 |
| Iriguchi, N | 1 |
| Toko, H | 1 |
| Takano, H | 1 |
| Akazawa, H | 1 |
| Alvarez, BV | 1 |
| Ennis, IL | 1 |
| De Hurtado, MC | 1 |
| Cingolani, HE | 1 |
| Phillips, RA | 2 |
| Ardeljan, M | 2 |
| Shimabukuro, S | 2 |
| Goldman, ME | 2 |
| Garbowit, DL | 2 |
| Eison, HB | 2 |
| Krakoff, LR | 2 |
| Schulte, KL | 1 |
| Meyer-Sabellek, W | 1 |
| Liederwald, K | 1 |
| van Gemmeren, D | 1 |
| Lenz, T | 1 |
| Gotzen, R | 1 |
| Nishimura, H | 1 |
| Kubota, J | 1 |
| Okabe, M | 1 |
| Ueyama, M | 1 |
| Kawamura, K | 1 |
| Shigematsu, S | 1 |
| Yamada, T | 1 |
| Aizawa, T | 1 |
| Takasu, N | 1 |
| Shimizu, Z | 1 |
| Otterstad, JE | 1 |
| Froeland, G | 1 |
| Wasenius Soeyland, AK | 1 |
| Knutsen, KM | 1 |
| Ekeli, T | 1 |
| Callens-el Amrani, F | 1 |
| Mayoux, E | 1 |
| Mouas, C | 1 |
| Clapier-Ventura, R | 1 |
| Henzel, D | 1 |
| Charlemagne, D | 1 |
| Swynghedauw, B | 1 |
| Cuspidi, C | 1 |
| Sampieri, L | 1 |
| Angioni, L | 1 |
| Boselli, L | 1 |
| Bragato, R | 1 |
| Leonetti, G | 1 |
| Zanchetti, A | 1 |
| Clark, WA | 1 |
| Rudnick, SJ | 1 |
| LaPres, JJ | 1 |
| Lesch, M | 1 |
| Decker, RS | 1 |
| Buser, PT | 1 |
| Wagner, S | 1 |
| Wu, S | 1 |
| Higgins, CB | 1 |
| Wikman-Coffelt, J | 1 |
| Nayler, WG | 3 |
| Ianovskiĭ, GV | 1 |
| Golub', NS | 1 |
| Vysotskaia, ZhM | 1 |
| Stadniuk, LA | 1 |
| Kovtun, LI | 1 |
| Gu, XH | 1 |
| Ivleva, AIa | 1 |
| Demidenko, IV | 1 |
| Krasnobaeva, GM | 1 |
| Strugovshchikov, AN | 1 |
| Moĭseev, VS | 1 |
| Cai, B | 1 |
| Sharaf el-Deane, MS | 1 |
| Parker, BM | 1 |
| Franz, IW | 5 |
| Tönnesmann, U | 5 |
| Behr, U | 5 |
| Ketelhut, R | 5 |
| Lee, RT | 1 |
| Lord, CP | 1 |
| Plappert, T | 1 |
| Sutton, MS | 1 |
| Rudzite, VK | 1 |
| Vitols, AV | 1 |
| Liepinja, DJ | 1 |
| Silava, AK | 1 |
| Viné, F | 1 |
| Bourdon, JL | 1 |
| Bragard, MF | 1 |
| Hayashi, H | 1 |
| Iwase, M | 1 |
| Aoki, T | 1 |
| Yokota, M | 1 |
| Sau, F | 1 |
| Seguro, C | 1 |
| Pili, G | 1 |
| Basciu, M | 1 |
| Siddi, PP | 1 |
| Tamponi, R | 1 |
| Cherchi, A | 1 |
| Mace, PJ | 1 |
| Littler, WA | 2 |
| Glover, DR | 1 |
| Rowlands, DB | 1 |
| Stallard, TJ | 1 |
| Motz, W | 4 |
| Sharma, RV | 1 |
| Butters, CA | 1 |
| Bhalla, RC | 1 |
| Sheiban, I | 1 |
| Arcaro, G | 1 |
| Covi, G | 1 |
| Accardi, R | 1 |
| Zenorini, C | 1 |
| Lechi, A | 1 |
| Kleine, P | 1 |
| Meissner, E | 1 |
| von Bruchhausen, V | 1 |
| Brückner, S | 1 |
| Klepzig, M | 1 |
| Matsubara, T | 1 |
| Yamazoe, M | 1 |
| Koike, T | 1 |
| Izumi, T | 1 |
| Shibata, A | 1 |
| Linz, W | 1 |
| Schölkens, BA | 1 |
| Ganten, D | 1 |
| Bestetti, RB | 1 |
| Pinto, LZ | 1 |
| Finzi, LA | 1 |
| Secches, AL | 1 |
| Bobrov, VA | 1 |
| Konoshevich, SN | 1 |
| Zähringer, J | 1 |
| Stangl, E | 1 |
| Danninger, B | 1 |
| Aschauer, W | 1 |
| Jennings, AA | 1 |
| Jee, LD | 1 |
| Smith, JA | 1 |
| Commerford, PJ | 1 |
| Nordlander, M | 1 |
| Di Bona, GF | 1 |
| Ljung, B | 1 |
| Yao, T | 1 |
| Thorén, P | 1 |
| Asai, M | 1 |
| Oki, T | 1 |
| Ohkushi, H | 1 |
| Ishimoto, T | 1 |
| Tominaga, T | 1 |
| Taoka, M | 1 |
| Fukuda, N | 1 |
| Niki, T | 1 |
| Mori, H | 1 |
| Michael, JR | 1 |
| Kennedy, TP | 1 |
| Buescher, P | 1 |
| Farrukh, I | 1 |
| Lodato, R | 1 |
| Rock, PC | 1 |
| Gottlieb, J | 1 |
| Gurtner, G | 1 |
| de la Monte, SM | 1 |
| Hutchins, GM | 1 |
| Anderson, P | 1 |
| Bradley, AB | 1 |
| Baim, DS | 1 |
| Stasch, JP | 1 |
| Kazda, S | 1 |
| Hirth, C | 1 |
| Morich, F | 1 |
| Alimento, M | 2 |
| Maltagliati, A | 2 |
| Tosi, E | 1 |
| Given, BD | 1 |
| Lee, TH | 1 |
| Stone, PH | 1 |
| Dzau, VJ | 1 |
| Bouthier, JD | 1 |
| De Luca, N | 1 |
| Safar, ME | 1 |
| Simon, AC | 1 |
5 reviews available for nifedipine and Cardiac Hypertrophy
| Article | Year |
|---|---|
Calcium channel blockers as antihypertensive agents.
Topics: Blood Pressure; Calcium Channel Blockers; Cardiomegaly; Clinical Trials as Topic; Coronary Disease; | 1984 |
The clinical uses of calcium antagonists.
Topics: Angina Pectoris; Angina Pectoris, Variant; Animals; Arrhythmias, Cardiac; Calcium; Calcium Channel B | 1982 |
Postinfarction cardiac dilatation. Is it modifiable?
Topics: Animals; Captopril; Cardiomegaly; Humans; Myocardial Contraction; Myocardial Infarction; Nifedipine; | 1990 |
Pharmacokinetics of calcium channel blocking agents.
Topics: Administration, Oral; Angina Pectoris; Atrial Fibrillation; Biological Availability; Cardiomegaly; C | 1986 |
Measurement of coronary blood flow in man: methods and implications for clinical practice.
Topics: Amrinone; Angina Pectoris; Animals; Cardiomegaly; Coronary Circulation; Coronary Disease; Coronary V | 1985 |
15 trials available for nifedipine and Cardiac Hypertrophy
| Article | Year |
|---|---|
Calcium channel blockers as antihypertensive agents.
Topics: Blood Pressure; Calcium Channel Blockers; Cardiomegaly; Clinical Trials as Topic; Coronary Disease; | 1984 |
Clinical use of calcium channel blockers as ventricular unloading agents.
Topics: Adult; Aged; Antihypertensive Agents; Calcium Channel Blockers; Cardiomegaly; Clinical Trials as Top | 1983 |
Calcium channel blocking agents.
Topics: Benzazepines; Calcium; Calcium Channel Blockers; Cardiomegaly; Clinical Trials as Topic; Coronary Di | 1981 |
[Acute action of nifedipine in patients with obstructive and nonobstructive asymmetrical septum hypertrophy (ASH)].
Topics: Adult; Cardiomegaly; Cardiomyopathy, Hypertrophic; Hemodynamics; Humans; Middle Aged; Nifedipine; Py | 1980 |
Relation of regression of left ventricular hypertrophy to changes in ambulatory blood pressure after long-term therapy with perindopril versus nifedipine.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Circadian Rhythm; Double-Blind M | 1992 |
Changes in left ventricular dimensions and systolic function in 100 mildly hypertensive men during one year's treatment with atenolol vs. hydrochlorothiazide and amiloride (Moduretic): a double-blind, randomized study.
Topics: Adult; Aged; Atenolol; Cardiomegaly; Double-Blind Method; Echocardiography; Humans; Hydrochlorothiaz | 1992 |
Normalization of left ventricular mass and associated changes in neurohormones and atrial natriuretic peptide after 1 year of sustained nifedipine therapy for severe hypertension.
Topics: Atrial Natriuretic Factor; Cardiomegaly; Chlorthalidone; Delayed-Action Preparations; Echocardiograp | 1991 |
[Regression of left ventricular hypertrophy in hypertensive patients under long-term therapy with antihypertensive agents].
Topics: Acebutolol; Adult; Antihypertensive Agents; Atenolol; Cardiomegaly; Female; Gallopamil; Humans; Hype | 1990 |
Assessment of left ventricular function after sublingual administration of nifedipine in patients with moderate to severe hypertension.
Topics: Administration, Sublingual; Adult; Blood Pressure; Cardiomegaly; Echocardiography; Echocardiography, | 1990 |
[Electrocardiographic and echocardiographic changes during antihypertensive therapy].
Topics: Acebutolol; Adolescent; Adult; Aged; Antihypertensive Agents; Captopril; Cardiomegaly; Chlorthalidon | 1990 |
Regression of left ventricular hypertrophy in hypertension: comparative effects of three different drugs.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Catecholamines; Female; Humans; Hypert | 1985 |
Regression of cardiac hypertrophy after antihypertensive therapy with nifedipine and captopril.
Topics: Adult; Blood Pressure; Captopril; Cardiomegaly; Echocardiography; Heart; Heart Rate; Humans; Hyperte | 1987 |
Effects of clonidine and nifedipine on left ventricular hypertrophy and muscle mass in hypertensive patients.
Topics: Adult; Aged; Blood Pressure; Cardiomegaly; Clonidine; Echocardiography; Female; Heart; Heart Rate; H | 1987 |
[Regression of left heart hypertrophy in hypertensive patients as a result of antihypertensive therapy].
Topics: Acebutolol; Adult; Antihypertensive Agents; Atenolol; Cardiac Output; Cardiac Volume; Cardiomegaly; | 1989 |
Pharmacokinetics of calcium channel blocking agents.
Topics: Administration, Oral; Angina Pectoris; Atrial Fibrillation; Biological Availability; Cardiomegaly; C | 1986 |
73 other studies available for nifedipine and Cardiac Hypertrophy
| Article | Year |
|---|---|
Recurrent cardiac tamponade in a young woman.
Topics: Adult; Cardiac Tamponade; Cardiomegaly; Cyclophosphamide; Female; Humans; Hypothyroidism; Nifedipine | 2013 |
Natriuretic Peptides as Cardiovascular Safety Biomarkers in Rats: Comparison With Blood Pressure, Heart Rate, and Heart Weight.
Topics: Animals; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Cardiomegaly; Heart Rate; Indoles; M | 2016 |
Early administration of nifedipine protects against angiotensin II-induced cardiomyocyte hypertrophy through regulating CaMKII-SERCA2a pathway and apoptosis in rat cardiomyocytes.
Topics: Angiotensin II; Animals; Apoptosis; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly | 2016 |
[Antihypertrophic effect of dihydropyridines calcium channel blockers is dependent on their potential of blocking N-type calcium channel].
Topics: Amlodipine; Animals; Calcium Channel Blockers; Calcium Channels, N-Type; Cardiomegaly; Dihydropyridi | 2010 |
Antihypertensive efficacy of Melothria maderaspatana leaf extract on sham-operated and uninephrectomized DOCA-salt hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiomegaly; Cucurbitac | 2010 |
Nifedipine inhibits cardiac hypertrophy and left ventricular dysfunction in response to pressure overload.
Topics: Algorithms; Animals; Blood Pressure; Calcium Channel Blockers; Calcium-Calmodulin-Dependent Protein | 2010 |
Ca(2+) influx through L-type Ca(2+) channels and transient receptor potential channels activates pathological hypertrophy signaling.
Topics: Animals; Calcineurin; Calcineurin Inhibitors; Calcium Channel Blockers; Calcium Channels, L-Type; Ca | 2012 |
[Effects of rho-kinase inhibitor on cardiac hypertrophy of left ventricle in spontaneously hypertensive rats].
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Cardiomegaly; Heart Ventricles; Male; Nifedi | 2012 |
Drugs and the heart. III. Calcium antagonists.
Topics: Angina Pectoris; Aniline Compounds; Arrhythmias, Cardiac; Calcium; Cardiomegaly; Diuretics; Heart Di | 1980 |
[Nifedipine in the treatment of hypertrophic non-obstructive cardiomyopathy].
Topics: Adult; Cardiac Catheterization; Cardiomegaly; Cardiomyopathy, Hypertrophic; Echocardiography; Female | 1982 |
Nifedipine in the treatment of primary pulmonary hypertension.
Topics: Adult; Cardiomegaly; Electrocardiography; Female; Humans; Hypertension, Pulmonary; Nifedipine; Physi | 1983 |
Cardiac rhythm in hypertension assessed through 24 hour ambulatory electrocardiographic monitoring. Effects of load manipulation with atenolol, verapamil, and nifedipine.
Topics: Adult; Atenolol; Cardiomegaly; Echocardiography; Electrocardiography; Female; Heart Conduction Syste | 1983 |
Hypoxia-induced cardiac hypertrophy in rabbits treated with verapamil and nifedipine.
Topics: Animals; Cardiomegaly; Eating; Hypoxia; Nifedipine; Organ Size; Rabbits; Verapamil | 1983 |
Assessment of left ventricular performance in patients with variable states of hypertrophy secondary to essential hypertension using a new load-independent index, E' max/V 100.
Topics: Adult; Aged; Cardiomegaly; Female; Heart; Hemodynamics; Humans; Hypertension; Isosorbide Dinitrate; | 1983 |
[Echocardiographic and arterial pressure changes after acute and prolonged (3 months) administration of nifedipine].
Topics: Adult; Aged; Blood Pressure; Cardiomegaly; Echocardiography; Edema; Heart; Humans; Hypertension; Leg | 1984 |
Left ventricular unloading with calcium antagonists.
Topics: Cardiac Output; Cardiomegaly; Drug Evaluation; Hemodynamics; Humans; Hypertension; Myocardial Contra | 1984 |
Regression of structural cardiovascular changes by antihypertensive therapy in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Cardiovascular System; Circadian Rhy | 1984 |
[Effects of nifedipine on left ventricular systolic and diastolic functions in left ventricular hypertrophy].
Topics: Adult; Calcium Channel Blockers; Cardiomegaly; Diastole; Female; Heart; Humans; Male; Middle Aged; M | 1984 |
Reversal of left ventricular hypertrophy and improvement of cardiac function in man by nifedipine.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Cardiomegaly; Cardiomyopathy, Dilated; Cardiomyopathy, | 1984 |
[Antihypertensives and the prevention of development of genetic hypertension in the hypertensive SHR rat].
Topics: Animals; Antihypertensive Agents; Atenolol; Captopril; Cardiomegaly; Dihydralazine; Dose-Response Re | 1980 |
Effect of the new calcium antagonist (+/-)-(R*)-3-[(R*)-1-benzyl-3- piperidyl] methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5- pyridinedicarboxylate hydrochloride (KW-3049) on cardiac hypertrophy in spontaneously hypertensive rats.
Topics: Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiomegal | 1993 |
Shaker-related potassium channel, Kv1.4, mRNA regulation in cultured rat heart myocytes and differential expression of Kv1.4 and Kv1.5 genes in myocardial development and hypertrophy.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
Regulation of membrane-mediated chronic muscle degeneration in dystrophic hamsters by calcium-channel blockers: diltiazem, nifedipine and verapamil.
Topics: Animals; Body Weight; Calcium; Calcium Channel Blockers; Cardiomegaly; Creatine Kinase; Cricetinae; | 1993 |
Effect of antihypertensive treatment and N omega-nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arteries; Blood Pressure | 1996 |
Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure.
Topics: Adrenergic beta-Agonists; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Chan | 1997 |
Efficient inhibition of the development of cardiac remodeling by a long-acting calcium antagonist amlodipine.
Topics: Amlodipine; Animals; Antihypertensive Agents; Calcium Channel Blockers; Cardiomegaly; Collagen; Hear | 1998 |
Effects of taurine on signal transduction steps induced during hypertrophy of rat heart myocytes.
Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Cells, Cultured; Heart; Myocardium; Nifedipine; Ouab | 1998 |
Nifedipine does not impede clenbuterol-stimulated muscle hypertrophy.
Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Body Weight; Calcium; Calcium Channels; Calcium C | 1999 |
Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats. Temporal regulation and spatial heterogeneity.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibit | 1999 |
Arterial responses in vitro and plasma digoxin immunoreactivity after losartan and enalapril treatments in experimental hypertension.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensiv | 2000 |
Possible involvement of endothelin-1 in cardioprotective effects of benidipine.
Topics: Animals; Animals, Newborn; Calcium Channel Blockers; Cardiomegaly; Cells, Cultured; Dihydropyridines | 2000 |
Continuous blockade of L-type Ca2+ channels suppresses activation of calcineurin and development of cardiac hypertrophy in spontaneously hypertensive rats.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Calcineurin Inhibitors; Calcium Channel Blockers | 2002 |
Effects of antihypertensive therapy on cardiac sodium/hydrogen ion exchanger activity and hypertrophy in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiomegaly; Disease Mo | 2002 |
Effects of nifedipine-GITS on left ventricular mass and left ventricular filling.
Topics: Atrial Natriuretic Factor; Cardiomegaly; Chlorthalidone; Delayed-Action Preparations; Drug Therapy, | 1992 |
Nifedipine in divided doses does not reverse left ventricular hypertrophy in spontaneously hypertensive rats.
Topics: Adrenergic Fibers; Animals; Blood Pressure; Body Weight; Cardiac Output; Cardiomegaly; Drug Administ | 1992 |
Differential effects of nifedipine on plasma atrial natriuretic peptide in normal subjects and hypertensive patients.
Topics: Adult; Aged; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Electrocardiography; Female; H | 1992 |
Normal responsiveness to external Ca and to Ca-channel modifying agents in hypertrophied rat heart.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Effects of long-term blood pressure control on left and right ventricular structure and function in hypertensive patients.
Topics: Blood Pressure; Captopril; Cardiomegaly; Echocardiography; Echocardiography, Doppler; Female; Heart | 1991 |
Hypertrophy of isolated adult feline heart cells following beta-adrenergic-induced beating.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Calcium; Cardiomegaly; Cats; Cells, Cultured; Colforsin; Cultu | 1991 |
Protective effects of calcium antagonists on energy and substrate metabolism during ischemia and reperfusion in hypertensive myocardial hypertrophy.
Topics: Adenosine Triphosphate; Animals; Calcium Channel Blockers; Cardiomegaly; Energy Metabolism; Hyperten | 1991 |
Vascular injury: mechanisms and manifestations.
Topics: Amlodipine; Animals; Aorta, Thoracic; Arteriosclerosis; Calcium; Calcium Channel Blockers; Cardiomeg | 1991 |
[Left ventricular hypertrophy as an indication for the prescribing of calcium antagonists in patients with ischemic heart disease].
Topics: Adult; Calcium Channel Blockers; Cardiomegaly; Coronary Disease; Drug Evaluation; Hemodynamics; Huma | 1991 |
Vascular and myocardial effects of amlodipine: an overview.
Topics: Amlodipine; Animals; Arteriosclerosis; Binding Sites; Calcium Channel Blockers; Cardiomegaly; Cerebr | 1991 |
[Transient subendocardial ischemia in abolition of hypertensive crises with nifedipine].
Topics: Adult; Aged; Blood Pressure; Cardiomegaly; Coronary Disease; Echocardiography; Electrocardiography; | 1991 |
[The effect of lowered pressure on the diastolic ventricular function after antihypertensive treatment].
Topics: Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Cardiomegaly; Diastole; Female; | 1991 |
Significance of coronary circulation in hypertensive heart disease for development and prevention of heart failure.
Topics: Adult; Animals; Cardiac Output, Low; Cardiomegaly; Coronary Circulation; Coronary Disease; Coronary | 1990 |
Effects of nifedipine on transmitral Doppler blood flow velocity profile in patients with concentric left ventricular hypertrophy.
Topics: Adult; Blood Flow Velocity; Blood Pressure; Cardiomegaly; Diastole; Echocardiography; Echocardiograp | 1990 |
Increased blood kynurenine level as a factor inhibiting the therapeutic effect of antihypertensive agents in combined long-term treatment of essential hypertension.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cardiac Volume; Cardiomegaly; Clonidine; Drug Therap | 1990 |
[Action of sublingual nifedipine on left ventricular filling in hypertensive crisis].
Topics: Administration, Sublingual; Adult; Aged; Aged, 80 and over; Blood Pressure; Cardiomegaly; Echocardio | 1990 |
Regression of cardiac hypertrophy after therapy in animal hypertension.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Hypertension; Nifedipine; Rats; Rats | 1985 |
Alterations in the plasma membrane properties of the myocardium of spontaneously hypertensive rats.
Topics: Adenosine Triphosphatases; Animals; Cardiomegaly; Cell Membrane; Ion Channels; Male; Myocardium; Nif | 1986 |
The effect of amlodipine on hypertension-induced cardiac hypertrophy and reperfusion-induced calcium overload.
Topics: Aging; Amlodipine; Animals; Blood Pressure; Calcium; Calcium Channel Blockers; Cardiomegaly; Coronar | 1988 |
Regression of cardiac hypertrophy: experimental and clinical results.
Topics: Animals; Cardiomegaly; Clonidine; Enalapril; Humans; Hypertension; Nifedipine; Prazosin; Rats; Rats, | 1987 |
Left ventricular function and collagen content after regression of hypertensive hypertrophy.
Topics: Animals; Cardiomegaly; Collagen; Heart; Hydroxyproline; Hypertension; Nifedipine; Rats; Rats, Inbred | 1989 |
A case of atrial septal defect combined with hypertension and left ventricular hypertrophy. Left ventricular failure induced by balloon occlusion and the effect of nifedipine.
Topics: Blood Pressure; Cardiac Output, Low; Cardiomegaly; Catheterization; Female; Heart Septal Defects, At | 1989 |
Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bridged | 1989 |
Impending myocardial infarction in a patient with marked left ventricular hypertrophy and normal coronary arteriogram--a case report.
Topics: Angiocardiography; Angiography; Cardiomegaly; Coronary Angiography; Echocardiography; Electrocardiog | 1989 |
[Nifedipine in the treatment of hypertension. An echocardiographic assessment of the hemodynamic effects].
Topics: Adult; Cardiomegaly; Drug Evaluation; Echocardiography; Heart; Hemodynamics; Humans; Hypertension; M | 1989 |
Regression of left ventricular hypertrophy by acebutolol and nifedipine.
Topics: Acebutolol; Blood Pressure; Cardiomegaly; Drug Combinations; Echocardiography; Humans; Hypertension; | 1989 |
Regression of heart muscle hypertrophy after nifedipine therapy: changes in cardiac gene expression.
Topics: Animals; Cardiomegaly; Gene Expression; Muscle Proteins; Myocardium; Nifedipine; Rats; Rats, Inbred | 1985 |
Acute effect of nifedipine on blood pressure and left ventricular ejection fraction in severely hypertensive outpatients: predictive effects of acute therapy and prolonged efficacy when added to existing therapy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Cardiomegaly; Drug Therapy, Combination; F | 1986 |
Renal and cardiovascular effects of acute and chronic administration of felodipine to SHR.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Felodipine; Furosemide; Heart Rate; | 1985 |
Use of nifedipine as monotherapy in the management of hypertension.
Topics: Adult; Blood Pressure; Cardiomegaly; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Ni | 1985 |
[Progression and regression of heart hypertrophy in arterial hypertension: pathophysiology and clinical aspects].
Topics: Blood Pressure; Cardiac Volume; Cardiomegaly; Cardiomyopathy, Hypertrophic; Clonidine; Coronary Circ | 1985 |
[Stress pulsed Doppler echocardiography in the evaluation of diastolic left ventricular function].
Topics: Cardiomegaly; Cardiomyopathy, Hypertrophic; Coronary Disease; Diastole; Echocardiography; Heart Vent | 1985 |
Nitrendipine attenuates the pulmonary vascular remodeling and right ventricular hypertrophy caused by intermittent hypoxia in rats.
Topics: Animals; Cardiomegaly; Heart Ventricles; Hypertension, Pulmonary; Hypertrophy; Hypoxia; Male; Muscle | 1986 |
Role of nisoldipine on blood pressure, cardiac hypertrophy, and atrial natriuretic peptides in spontaneously hypertensive rats.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Hypertension; Male; Nifedipine; Ni | 1987 |
Cardiac hypertrophy in hypertension. Repolarization abnormalities elicited by rapid lowering of pressure.
Topics: Adult; Blood Pressure; Cardiomegaly; Electrocardiography; Female; Heart Rate; Humans; Hypertension; | 1988 |
Long-term effect of antihypertensive therapy on left ventricular hypertrophy.
Topics: Adult; Antihypertensive Agents; Atenolol; Cardiomegaly; Drug Therapy, Combination; Echocardiography; | 1987 |
Regression of left ventricular hypertrophy during combined atenolol and nifedipine treatment.
Topics: Adult; Atenolol; Blood Pressure; Cardiomegaly; Drug Therapy, Combination; Echocardiography; Exercise | 1988 |
Electrocardiographic alterations suggestive of myocardial injury elicited by rapid pressure lowering in hypertension.
Topics: Adult; Blood Pressure; Cardiomegaly; Coronary Circulation; Electrocardiography; Ferricyanides; Heart | 1988 |
Nifedipine in severely hypertensive patients with congestive heart failure and preserved ventricular systolic function.
Topics: Aged; Cardiomegaly; Electrocardiography; Female; Heart Failure; Heart Ventricles; Humans; Hypertensi | 1985 |
Cardiac hypertrophy and arterial distensibility in essential hypertension.
Topics: Adult; Aged; Arteries; Blood Flow Velocity; Cardiomegaly; Humans; Hypertension; Middle Aged; Nifedip | 1985 |